Moderna Executive and Leadership Team

John Joyal, the Chief Operating Officer, Research & Head of Biological Science at Moderna, manages the end-to-end execution of laboratory research and biological development programs. Overseeing the integration of mRNA technology into clinical applications, the Chief Operating Officer, Research & Head of Biological Science coordinates cross-functional teams to accelerate the transition from discovery to human trials. This role requires precise management of scientific resources to address infectious conditions and complex autoimmune challenges. By streamlining internal research protocols, John Joyal ensures that biological science initiatives remain aligned with the company's overarching goal of rapid therapeutic delivery. Joyal facilitates collaboration between laboratory scientists and clinical development units to maintain high standards of innovation. Through the optimization of research workflows, the Chief Operating Officer, Research & Head of Biological Science secures the technical foundation necessary for the company's continued leadership in the pharmaceutical industry.

Kei Kaneda, the Representative Director & President at Moderna, oversees the strategic direction and corporate governance of regional operations. Directing the alignment of local business activities with the company's global mission, the Representative Director & President manages stakeholder relationships and regulatory compliance within key markets. This leadership role involves coordinating with the executive team to ensure that mRNA-based therapeutic initiatives are executed with precision and cultural sensitivity. By fostering partnerships with local healthcare institutions, Kei Kaneda expands the reach of the company's vaccine and treatment portfolios. Kaneda maintains oversight of regional performance metrics to ensure that operational goals support the broader corporate strategy. Through the effective management of regional resources, the Representative Director & President drives the company's impact on public health, ensuring that innovative mRNA solutions are accessible and effectively integrated into the medical landscape of the assigned territory.

Sam Ismail, the Chief Marketing Officer & Senior Analyst at Moderna, directs the strategic positioning of mRNA therapeutic platforms within competitive global pharmaceutical markets. Overseeing market intelligence initiatives, the Chief Marketing Officer & Senior Analyst evaluates complex data sets to identify emerging opportunities for vaccine distribution across North American and European territories. This leadership role involves synthesizing clinical trial outcomes into actionable commercial narratives that resonate with healthcare providers and regulatory bodies. By aligning promotional activities with the broader mission of mRNA medicine, Sam Ismail ensures consistent brand messaging across diverse therapeutic portfolios. Ismail maintains rigorous oversight of analytical frameworks to optimize product adoption rates. Through the integration of advanced market analytics, the Chief Marketing Officer & Senior Analyst drives sustainable growth and enhances the visibility of the company's pipeline in the evolving landscape of modern medicine.

Sameh Ismail, the Chief Marketing Officer & Senior Analyst at Moderna, architects the commercialization strategies for mRNA-based medicines within emerging international markets. Overseeing regional market penetration, the Chief Marketing Officer & Senior Analyst evaluates macroeconomic trends to tailor vaccine access programs for diverse patient populations. This leadership role involves managing the interface between clinical data and commercial viability to ensure that therapeutic solutions reach target demographics effectively. By analyzing competitive dynamics, Sameh Ismail supports the expansion of the company's footprint in global health sectors. Ismail directs the development of sophisticated forecasting models to anticipate demand for new mRNA treatments. Through the application of rigorous analytical standards, the Chief Marketing Officer & Senior Analyst drives the strategic alignment of marketing efforts with the company's long-term objectives for addressing rare disorders and infectious diseases on a global scale.

Richard Mason, the Senior Specialist, External Manufacturing - Chief Marketing Officer Operations at Moderna, manages the logistical coordination between third-party manufacturing partners and internal commercial operations. Overseeing the supply chain integrity for mRNA products, the Senior Specialist, External Manufacturing - Chief Marketing Officer Operations ensures that production capacity meets the global demand for vaccines and therapeutic treatments. This role involves negotiating manufacturing agreements and monitoring quality control standards across international production facilities. By synchronizing external manufacturing output with marketing timelines, Richard Mason facilitates the seamless delivery of medical solutions to healthcare systems. Mason maintains oversight of operational efficiency to mitigate risks within the supply chain. Through the optimization of manufacturing partnerships, the Senior Specialist, External Manufacturing - Chief Marketing Officer Operations supports the company's mission to provide scalable and reliable access to life-saving mRNA medicines across diverse geographic regions.

Tracey Franklin, the Chief People & Digital Technology Officer at Moderna, directs the integration of human capital management with advanced digital infrastructure to support the company's scientific mission. Overseeing global talent acquisition and organizational development, the Chief People & Digital Technology Officer fosters a culture of innovation that attracts top-tier researchers and operational experts. This role involves implementing digital transformation initiatives that enhance internal collaboration and data security across the enterprise. By aligning workforce capabilities with technological advancements, Tracey Franklin ensures that the company maintains a competitive edge in the pharmaceutical industry. Franklin manages the deployment of digital tools to streamline administrative processes and improve employee engagement. Through the strategic alignment of people and technology, the Chief People & Digital Technology Officer drives the operational excellence required to sustain the company's rapid growth and commitment to improving human health through mRNA medicine.